Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Fell

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Neuro-Oncology|April 28, 2020
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the ElderlyShervin Tabrizi, Lorenzo Trippa, Daniel Cagney, et al.
Neuro-Oncology|June 4, 2019
To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designsAlyssa M Vanderbeek, Steffen Ventz, Rifaquat Rahman, et al.
Blood Neoplasia|June 2, 2025
Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCNNaveen Pemmaraju, Luan Hai Phan, Geoffrey Fell, et al.
Cancer Research and Treatment|September 12, 2024
Choosing Wisely between Radiotherapy Dose-Fractionation Schedules: The Molecular Graded Prognostic Assessment for Elderly Glioblastoma PatientsHye In Lee, Jina Kim, In Ah Kim, et al.
Database : the Journal of Biological Databases and Curation|June 25, 2021
KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trialsGeoffrey Fell, Robert A Redd, Alyssa M Vanderbeek, et al.
British Journal of Haematology|June 29, 2022
Peripheral blood CD3<sup>+</sup> T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignanciesGeoffrey Fell, Ashley E Rosko, Gregory A Abel, et al.
Neuro-Oncology|March 9, 2018
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?Alyssa M Vanderbeek, Rifaquat Rahman, Geoffrey Fell, et al.
NPJ Breast Cancer|March 12, 2025
Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsiesYael Bar, Geoffrey Fell, Aylin Dedeoglu, et al.
The New England Journal of Medicine|June 21, 2024
Brigatinib in <i>NF2</i>-Related Schwannomatosis with Progressive TumorsScott R Plotkin, Kaleb H Yohay, Phioanh L Nghiemphu, et al.
NPJ Breast Cancer|August 1, 2025
Selection biases in the systematic collection of breast biobank specimensYael Bar, Gary X Wang, Gabrielle E Gioia, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Neuro-Oncology|April 28, 2020
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the ElderlyShervin Tabrizi, Lorenzo Trippa, Daniel Cagney, et al.
Neuro-Oncology|June 4, 2019
To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designsAlyssa M Vanderbeek, Steffen Ventz, Rifaquat Rahman, et al.
Blood Neoplasia|June 2, 2025
Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCNNaveen Pemmaraju, Luan Hai Phan, Geoffrey Fell, et al.
Cancer Research and Treatment|September 12, 2024
Choosing Wisely between Radiotherapy Dose-Fractionation Schedules: The Molecular Graded Prognostic Assessment for Elderly Glioblastoma PatientsHye In Lee, Jina Kim, In Ah Kim, et al.
Database : the Journal of Biological Databases and Curation|June 25, 2021
KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trialsGeoffrey Fell, Robert A Redd, Alyssa M Vanderbeek, et al.
British Journal of Haematology|June 29, 2022
Peripheral blood CD3<sup>+</sup> T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignanciesGeoffrey Fell, Ashley E Rosko, Gregory A Abel, et al.
Neuro-Oncology|March 9, 2018
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?Alyssa M Vanderbeek, Rifaquat Rahman, Geoffrey Fell, et al.
NPJ Breast Cancer|March 12, 2025
Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsiesYael Bar, Geoffrey Fell, Aylin Dedeoglu, et al.
The New England Journal of Medicine|June 21, 2024
Brigatinib in <i>NF2</i>-Related Schwannomatosis with Progressive TumorsScott R Plotkin, Kaleb H Yohay, Phioanh L Nghiemphu, et al.
NPJ Breast Cancer|August 1, 2025
Selection biases in the systematic collection of breast biobank specimensYael Bar, Gary X Wang, Gabrielle E Gioia, et al.
Pageof 5